Average Co-Inventor Count = 6.31
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (18 from 212 patents)
2. Merck Frosst Canada & Co. (12 from 80 patents)
3. Constellation Pharmaceuticals, Inc. (4 from 55 patents)
4. Infinity Pharmaceuticals, Inc. (3 from 108 patents)
5. Genentech, Inc. (2 from 3,224 patents)
6. Merck Canada Inc. (2 from 40 patents)
7. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
8. Cantero Therapeutics, Inc. (1 from 1 patent)
9. Purdue Research Foundation (2,668 patents)
10. Dh Technologies Development Pte. Ltd. (376 patents)
40 patents:
1. 11401246 - Triazole glycolate oxidase inhibitors
2. 10206931 - Therapeutic compounds and uses thereof
3. 9522920 - Bromodomain inhibitors and uses thereof
4. 9505767 - Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors
5. 9149465 - Isoxazolines as inhibitors of fatty acid amide hydrolase
6. 8927551 - Isoxazolines as inhibitors of fatty acid amide hydrolase
7. 8796261 - Bromodomain inhibitors and uses thereof
8. 8765735 - Isoxazolines as inhibitors of fatty acid amide hydrolase
9. 8546422 - Azaindole derivatives as CRTH2 receptor antagonists
10. 8518964 - Tricyclic compounds useful as inhibitors of kinases
11. 7618979 - Pyridopyrrolizine and pyridoindolizine derivatives
12. 7582633 - Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
13. 7429666 - Pyridine analogs as C5a antagonists
14. 7163932 - Aryldifluoromethylphosphonic acids for treatment of diabetes
15. 7144913 - Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists